PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-22.48%
Negative net income growth while AVGO stands at 878.54%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
No Data
No Data available this quarter, please select a different quarter.
-56.86%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
7.04%
Less SBC growth vs. AVGO's 18.65%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
-240.00%
Both reduce yoy usage, with AVGO at -310.61%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-2242.86%
AR is negative yoy while AVGO is 741.94%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
76.32%
Inventory shrinking or stable vs. AVGO's 1662.50%, indicating lean supply management. David Dodd would confirm no demand shortfall.
-291.18%
Both negative yoy AP, with AVGO at -539.68%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-411.54%
Both reduce yoy usage, with AVGO at -250.32%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
61.54%
Well above AVGO's 62.54%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-60.89%
Both yoy CFO lines are negative, with AVGO at -13.99%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-5.88%
Negative yoy CapEx while AVGO is 5.58%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
400.00%
Some acquisitions while AVGO is negative at -1010.00%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
95.37%
Some yoy expansion while AVGO is negative at -3385.71%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
50.53%
Proceeds from sales/maturities above 1.5x AVGO's 18.50%. David Dodd would confirm if the firm is capitalizing on strong valuations or freeing liquidity for expansions.
-150.00%
We reduce yoy other investing while AVGO is 200.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
302.14%
We have mild expansions while AVGO is negative at -1167.42%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-167.70%
We cut debt repayment yoy while AVGO is 78.40%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
100.00%
We slightly raise equity while AVGO is negative at -48.48%. John Neff sees competitor possibly preserving share count or buying back shares.
9.52%
Buyback growth of 9.52% while AVGO is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.